Entering into joint venture contracts between Shanghai Zuquan Investment Management Company Limited on one side and Epygon, Kephalios and MyoPowers on the other side.
Recent Posts
- Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
- Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
- Spécialiste produit – Urologie
- Successful first-in-human implantation of artificial sphincter Artus for the treatment of stress urinary incontinence
- PCR London Valves – Conference, London
Recent Comments